+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell Therapy Technologies Market by Product, Process, Cell Type, End-User - Global Forecast 2025-2030- Product Image
Cell Therapy Technologies Market by Product, Process, Cell Type, End-User - Global Forecast 2025-2030- Product Image
Sale

Cell Therapy Technologies Market by Product, Process, Cell Type, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4995207
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cell Therapy Technologies Market grew from USD 19.48 billion in 2023 to USD 22.31 billion in 2024. It is expected to continue growing at a CAGR of 14.63%, reaching USD 50.69 billion by 2030.

Cell therapy technologies encompass a broad range of therapeutic approaches involving the use of cells to treat or potentially cure diseases. This rapidly evolving field includes stem cell therapies, autologous and allogenic cell therapies, and emerging use of chimeric antigen receptor (CAR) T-cells among others. The necessity of cell therapy technologies arises from their potential to address unmet medical needs for chronic, degenerative, and lethal diseases such as cancer, Parkinson's, and heart diseases, where traditional therapies have limitations. These technologies find applications in regenerative medicine, oncology, cardiology, orthopedic, and neurology, offering a paradigm shift from symptomatic treatment to targeting the root causes of disease. The end-use scope spans hospitals, clinics, and research institutes, with growing adoption in academic settings for pioneering novel applications.

The market is bolstered by factors such as an increasing prevalence of chronic diseases, advancements in genetic engineering technologies, and supportive regulatory policies in regions like North America and Europe. However, challenges include high treatment costs, complex manufacturing processes, ethical concerns, and stringent regulatory frameworks that pose barriers to market expansion. Despite these hindrances, opportunities abound, particularly with advancements in personalized medicine, and the collaboration between biotech firms and research institutions to accelerate innovation. Companies can capitalize on these trends by investing in scalable manufacturing processes and building strategic alliances to enhance product pipelines.

Innovation can be sparked by focusing on improving CAR-T cell technologies, exploring off-the-shelf solutions, and integrating artificial intelligence to optimize cell selection and therapy outcomes. The competitive landscape is characterized by rapid technological advancements and a growing number of startups, fostering a dynamic market nature that requires adaptability and continuous learning. Engaging in partnerships, advancing clinical trials, and addressing critical regulatory challenges are recommended strategies to thrive, with a push towards democratizing access to these cutting-edge therapies being a pivotal area for industry growth.

Understanding Market Dynamics in the Cell Therapy Technologies Market

The Cell Therapy Technologies Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing incidence of chronic diseases and infections globally
    • Rising GMP certifications for cell therapy production facilities
    • Surge in government initiatives through investments in cell-based research
  • Market Restraints
    • High costs associated with cell therapy technologies
  • Market Opportunities
    • Ongoing focus on personalized medicine
    • Emergence of iPSCs as an alternative to ESCs in technologies
  • Market Challenges
    • Dearth of skilled professionals and stringent regulatory framework

Exploring Porter’s Five Forces for the Cell Therapy Technologies Market

Porter’s Five Forces framework further strengthens the insights of the Cell Therapy Technologies Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Cell Therapy Technologies Market

External macro-environmental factors deeply influence the performance of the Cell Therapy Technologies Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Cell Therapy Technologies Market

The Cell Therapy Technologies Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Cell Therapy Technologies Market

The Cell Therapy Technologies Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Cell Therapy Technologies Market

The Cell Therapy Technologies Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Therapy Technologies Market, highlighting leading vendors and their innovative profiles. These include Anterogen Co., Ltd., Atara Biotherapeutics by FUJIFILM Corporation, Athersys, Inc., Becton, Dickinson and Company, Bluebird Bio, Inc., Bristol-Myers Squibb Company, Cellectis SA, Danaher Corporation, ElevateBio, Gamida Cell, GE Healthcare, Gilead Sciences, Inc., JCR Pharmaceuticals Co., Ltd., Johnson & Johnson Services, Inc., Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Novartis AG, Sartorius AG, STEMCELL Technologies Inc., Takeda Pharmaceutical Company Limited, Tego Science, Terumo Bct, Inc., Thermo Fisher Scientific, Inc., and Vericel Corporation.

Market Segmentation & Coverage

This research report categorizes the Cell Therapy Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Consumables
    • Equipment
      • Cell Processing Equipment
      • Single-Use Equipment
    • Software
  • Process
    • Cell Preservation, Distribution, & Handling
    • Cell Processing
    • Process Monitoring & Quality Control
  • Cell Type
    • Animal Cells
    • Human Cells
      • Differentiated Cells
      • Stem Cells
  • End-User
    • Healthcare & Life Science
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidence of chronic diseases and infections globally
5.1.1.2. Rising GMP certifications for cell therapy production facilities
5.1.1.3. Surge in government initiatives through investments in cell-based research
5.1.2. Restraints
5.1.2.1. High costs associated with cell therapy technologies
5.1.3. Opportunities
5.1.3.1. Ongoing focus on personalized medicine
5.1.3.2. Emergence of iPSCs as an alternative to ESCs in technologies
5.1.4. Challenges
5.1.4.1. Dearth of skilled professionals and stringent regulatory framework
5.2. Market Segmentation Analysis
5.2.1. Product: The advent of big data analytics tools driving the adoption of software tools for cell therapies
5.2.2. Process: Advancements in cell preservation technologies
5.2.3. Cell type: Rising utilization of human cells in cell and gene therapies
5.2.4. End user: Government initiatives to propel investments in research institutes
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Cell Therapy Technologies Market, by Product
6.1. Introduction
6.2. Consumables
6.3. Equipment
6.3.1. Cell Processing Equipment
6.3.2. Single-Use Equipment
6.4. Software
7. Cell Therapy Technologies Market, by Process
7.1. Introduction
7.2. Cell Preservation, Distribution, & Handling
7.3. Cell Processing
7.4. Process Monitoring & Quality Control
8. Cell Therapy Technologies Market, by Cell Type
8.1. Introduction
8.2. Animal Cells
8.3. Human Cells
8.3.1. Differentiated Cells
8.3.2. Stem Cells
9. Cell Therapy Technologies Market, by End-User
9.1. Introduction
9.2. Healthcare & Life Science
9.3. Research Institutes
10. Americas Cell Therapy Technologies Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cell Therapy Technologies Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cell Therapy Technologies Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Clade Therapeutics Announces the Acquisition of Gadeta B.V.
13.3.2. Startup Cellares adds USD 255 million as investors pour cash into cell therapy production
13.3.3. NewBiologix Launches with USD 50 million to Advance Novel Technology Platform for the Manufacturing of Gene and Cell Therapies
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. CELL THERAPY TECHNOLOGIES MARKET RESEARCH PROCESS
FIGURE 2. CELL THERAPY TECHNOLOGIES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. CELL THERAPY TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. CELL THERAPY TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CELL THERAPY TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CELL THERAPY TECHNOLOGIES MARKET DYNAMICS
TABLE 7. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PROCESSING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY SINGLE-USE EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PRESERVATION, DISTRIBUTION, & HANDLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS MONITORING & QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY ANIMAL CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY DIFFERENTIATED CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HEALTHCARE & LIFE SCIENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 48. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 49. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 50. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 51. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 54. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 55. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 56. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 57. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 80. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 81. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 82. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 83. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 86. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 87. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 88. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 89. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 98. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 99. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 100. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 101. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 110. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 134. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 135. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 136. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 137. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 151. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 152. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 153. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 154. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 155. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 156. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 159. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 160. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 161. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 162. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 165. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 166. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 167. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 168. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 171. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 172. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 173. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 174. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 177. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 178. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 179. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 180. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 189. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 190. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 191. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 192. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 199. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 207. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 208. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 209. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 210. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 212. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 213. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 214. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 215. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 216. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 219. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 220. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 221. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 222. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 241. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 242. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 243. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 244. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 245. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 246. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 253. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 259. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 260. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 261. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 262. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 263. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 264. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 272. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 277. CELL THERAPY TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 278. CELL THERAPY TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Cell Therapy Technologies Market, which are profiled in this report, include:
  • Anterogen Co., Ltd.
  • Atara Biotherapeutics by FUJIFILM Corporation
  • Athersys, Inc.
  • Becton, Dickinson and Company
  • Bluebird Bio, Inc.
  • Bristol-Myers Squibb Company
  • Cellectis SA
  • Danaher Corporation
  • ElevateBio
  • Gamida Cell
  • GE Healthcare
  • Gilead Sciences, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • Johnson & Johnson Services, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Miltenyi Biotec B.V. & Co. KG
  • Novartis AG
  • Sartorius AG
  • STEMCELL Technologies Inc.
  • Takeda Pharmaceutical Company Limited
  • Tego Science
  • Terumo Bct, Inc.
  • Thermo Fisher Scientific, Inc.
  • Vericel Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 22.31 Billion
Forecasted Market Value ( USD ) by 2030 $ 50.69 Billion
Compound Annual Growth Rate14.6%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Cell & Gene Therapy Clinical Trials Market by Type, Phase, Application, End-User - Global Forecast 2025-2030 - Product Image

Cell & Gene Therapy Clinical Trials Market by Type, Phase, Application, End-User - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Cell Therapy Market by Cell Type, Therapy Type, Application, End-User - Global Forecast 2025-2030 - Product Image

Cell Therapy Market by Cell Type, Therapy Type, Application, End-User - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Cell Therapy Human Raw Materials Market Size, Share & Trends Analysis Report, Product (Cell Culture Media, Cell Culture Sera, Cell Culture Supplements), End Use, Region, and Segment Forecasts, 2024-2030 - Product Image

Cell Therapy Human Raw Materials Market Size, Share & Trends Analysis Report, Product (Cell Culture Media, Cell Culture Sera, Cell Culture Supplements), End Use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Automated And Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report By Workflow (Separation), By Type (Stem Cell Therapy), By Scale (Commercial Scale), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Automated And Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report By Workflow (Separation), By Type (Stem Cell Therapy), By Scale (Commercial Scale), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 130 Pages
  • Global
From
CAR T Cell Therapy Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Target Indication, Target Antigens, Key Geographical Regions, Key Players and Sales Forecast - Product Image

CAR T Cell Therapy Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Target Indication, Target Antigens, Key Geographical Regions, Key Players and Sales Forecast

  • Report
  • 640 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.